BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 19122570)

  • 1. Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.
    Zubkov AY; Wijdicks EF
    Rev Neurol Dis; 2008; 5(4):178-81. PubMed ID: 19122570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of delayed seizures, delayed cerebral ischemia and poor outcome with the use of levetiracetam versus phenytoin after aneurysmal subarachnoid hemorrhage.
    Karamchandani RR; Fletcher JJ; Pandey AS; Rajajee V
    J Clin Neurosci; 2014 Sep; 21(9):1507-13. PubMed ID: 24919470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
    Cotton BA; Kao LS; Kozar R; Holcomb JB
    J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain.
    Kim JS; Kondratyev A; Tomita Y; Gale K
    Epilepsia; 2007; 48 Suppl 5():19-26. PubMed ID: 17910577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antiepileptic drugs in pediatric brain tumor patients.
    Sogawa Y; Kan L; Levy AS; Maytal J; Shinnar S
    Pediatr Neurol; 2009 Sep; 41(3):192-4. PubMed ID: 19664535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage.
    Bansal S; Blalock D; Kebede T; Dean NP; Carpenter JL
    J Neurosurg Pediatr; 2014 Feb; 13(2):209-15. PubMed ID: 24286154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizures and anticonvulsants after aneurysmal subarachnoid hemorrhage.
    Lanzino G; D'Urso PI; Suarez J;
    Neurocrit Care; 2011 Sep; 15(2):247-56. PubMed ID: 21751102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures and Choice of Antiepileptic Drugs Following Subarachnoid Hemorrhage: A Review.
    Mahmoud SH; Buxton J
    Can J Neurol Sci; 2017 Nov; 44(6):643-653. PubMed ID: 29391074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs.
    Wychowski T; Wang H; Buniak L; Henry JC; Mohile N
    Clin Neurol Neurosurg; 2013 Nov; 115(11):2365-9. PubMed ID: 24054994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam for seizures after liver transplantation.
    Glass GA; Stankiewicz J; Mithoefer A; Freeman R; Bergethon PR
    Neurology; 2005 Mar; 64(6):1084-5. PubMed ID: 15781837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent levetiracetam dosing in a patient with refractory daily seizures.
    Friedman D; French JA
    Neurology; 2006 Feb; 66(4):590-1. PubMed ID: 16505320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.
    Kruer RM; Harris LH; Goodwin H; Kornbluth J; Thomas KP; Slater LA; Haut ER
    J Crit Care; 2013 Oct; 28(5):883.e9-13. PubMed ID: 23566730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of seizure onset after intracerebral hemorrhage and the role of long-term antiepileptic therapy.
    Garrett MC; Komotar RJ; Starke RM; Merkow MB; Otten ML; Connolly ES
    J Crit Care; 2009 Sep; 24(3):335-9. PubMed ID: 19327321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drugs and neuroprotection: current status and future roles.
    Willmore LJ
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizures in patients with glioma treated with phenytoin and levetiracetam.
    Merrell RT; Anderson SK; Meyer FB; Lachance DH
    J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V; Pierguidi L; Tambasco N
    Brain Dev; 2011 Apr; 33(4):289-93. PubMed ID: 20630672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage.
    Wang H; Gao J; Lassiter TF; McDonagh DL; Sheng H; Warner DS; Lynch JR; Laskowitz DT
    Neurocrit Care; 2006; 5(1):71-8. PubMed ID: 16960300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis.
    Szaflarski JP; Sangha KS; Lindsell CJ; Shutter LA
    Neurocrit Care; 2010 Apr; 12(2):165-72. PubMed ID: 19898966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam Versus Phenytoin for Seizure Prophylaxis Following Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
    Yang Y; Zheng F; Xu X; Wang X
    CNS Drugs; 2016 Aug; 30(8):677-88. PubMed ID: 27395404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizures and CNS hemorrhage: spontaneous intracerebral and aneurysmal subarachnoid hemorrhage.
    Gilmore E; Choi HA; Hirsch LJ; Claassen J
    Neurologist; 2010 May; 16(3):165-75. PubMed ID: 20445426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.